Prostate Cancer
Study confirms treating prostate cancer preferable to watchful waiting
Published in Cancer Weekly, January 23rd, 2007
The study consisted of 44,630 men between the ages of 65 and 80 and found that those patients who chose to treat their prostate cancer were 30% less likely to die than those who waited. This suggests that all patients with localized disease regardless of age should consider definitive treatments rather than "watchful waiting." It is estimated that approximately 30,000 of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-01-23)
More Articles from Cancer Weekly
- Cancer Therapy
Study finds long-term risk of soft tissue sarcomas in hereditary retinoblastoma survivors - Lung Cancer
Point Therapeutics finalizes data from Phase II non-small cell lung cancer study - Cancer Gene Therapy
Data from Shanghai Jiao Tong University, Department of Gastroenterology advance knowledge in cancer gene therapy - Cancer Gene Therapy
Data on cancer gene therapy described by researchers at Memorial Sloan Kettering Cancer Center, Department of Surgery - Cancer Gene Therapy
Data on cancer gene therapy detailed by researchers at National Institutes of Health - Cancer Gene Therapy
Findings in cancer gene therapy reported from Pomeranian Medical University, International Hereditary Cancer Center - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
